Navigation Links
Ruling enforces international trademark electronic filing requirements

Businesses could lose important trademark rights by failing to meet the technical filing requirements of the U.S. Patent and Trademark Office and the Trademark Trial and Appeal Board, as demonstrated by an international case of earlier this year.

In the case, In re Borlind Gesellschaft for kosmetische Erzeugnisse mbH, the Trademark Trial and Appeal Bo......

Full article >>> ed States, the PTO had to change the rules for filing oppositions or requests for extensions of time to file oppositions to Madrid Protocol applications and require that they be filed electronically via ESTTA. Electronic filings can be processed almost immediately by the PTO, whereas paper filings can take weeks or even months to be collected and reviewed.

In re Borlind illustrates......

Full article >>> l continue to be challenged with the task of keeping up with the resulting changes to PTO rules. Significantly, despite the result in In re Borlind, issued in January, there have been at least three subsequent TTAB decisions where the board has had to deny requests for extension of time to oppose Madrid Protocol applications because the potential opposer had failed to use the electronic fil......

Full article >>>
'"/>

Source:wistechnology.com By Ariana Voight 10/12/05


Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. 30 days to success: Three simple steps to create your own international startup
4. Internet trademark war goes international
5. Lack of broadband hamstrings international videoconferencing
6. Wisconsin business leads small delegation to international BIO Conference
7. Early Stage, Step 4: Cautionary trademark tales
8. SC Johnson issues trademark warning over web offer
9. NameProtect releases annual list of top trademarkers
10. Why file for trademark protection?
11. Global branding is easy with global trademarks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... ... May 18, 2016 , ... Tech Coast Angels (TCA) ... to Cognition Therapeutics at the annual ACA Summit last week in Philadelphia. ... one of ACA’s member angel groups. It is the highest honor available for an ...
(Date:5/18/2016)... May 18, 2016 The Biotech industry ... not mean that there are no opportunities ahead. Today, ActiveWallSt.com ... (NASDAQ: THLD ), Seattle Genetics Inc. (NASDAQ: ... and Ophthotech Corp. (NASDAQ: OPHT ). Sign up ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s ...
(Date:5/18/2016)... ... May 18, 2016 , ... Every day, ... result of asthma complications.* Costing more than $56 billion in direct costs annually, ... , “For too many, the suffering associated with uncontrolled asthma can be overwhelmingly ...
Breaking Biology Technology:
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):